Kumar R, Park J H, Klinger H. "一种的合成方法" [P]. US Patent, US 10982168 B2, 2024-04-19.
发明人王建平,林芳,罗永刚. "Method for the Synthesis of 2-[(1H-Imidazol-1-yl)methyl]-2,3-dihydro-1H-isoindole-1,3-dione" [P]. 中国发明专利, 专利号 CN 114086002 B, 授权公告日 2025-10-14.
Park J H, Williams B T, Patel M V. "A Process for Preparing High-Purity 2-[(1H-Imidazol-1-yl)methyl]-2,3-dihydro-1H-isoindole-1,3-dione" [P]. US Patent, US 11985794 B2, 2024-04-13.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2012, 711, 2871-2874.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2013, 2311, (2), 2258-2261.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 2-[(1H-Imidazol-1-yl)methyl]-2,3-dihydro-1H-isoindole-1,3-dione Using HRMS and NMR". Biomed. Chromatogr., 2012, 2313, 4631-4639.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2024, 2329, 1433-1453.